Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magcaldi
- Development stage
- Unknown
- Lead developer
- Max Biocare
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
`Magcaldi` is a dietary supplement formulated to support bone and muscle health. Developed by Max Biocare and distributed in Vietnam by Dong Do Pharmaceutical, the product is a fixed-dose combination of calcium citrate tetrahydrate, heavy magnesium oxide, and colecalciferol (vitamin D3). Calcium serves as a primary structural component of bone tissue, while vitamin D3 enhances intestinal calcium absorption and renal reabsorption. Magnesium acts as an essential cofactor for vitamin D metabolism and parathyroid hormone regulation, helping to maintain mineral balance. Magcaldi is indicated for the prevention of osteoporosis in adults and rickets in children, as well as supporting bone mineralization and muscle function.
- Brand names
- Magcaldi
- Other names
- calcium citrate + magnesium oxide + cholecalciferolcalcium citrate + magnesium oxide + vitamin D3
02
Targets
CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Magcaldi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Magcaldi.